skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The role of constitutively activated STAT3 in B16 melanoma cells

Original Research

(2846) Views  (1039) Full article downloads

Authors: Chuan He Yang, Meiyun Fan, Andrzej T Slominski, et al

Published Date January 2010 Volume 2010:2 Pages 1 - 7
DOI: http://dx.doi.org/10.2147/IJICMR.S6657

Chuan He Yang1, Meiyun Fan1, Andrzej T Slominski1, Junming Yue2, Lawrence M Pfeffer1

1Department of Pathology and Laboratory Medicine, 2Department of Physiology, University of Tennessee Health Science Center and the Center for Cancer Research, Memphis, TN, USA

Abstract: Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.

Keywords: STAT3, melanoma, invasion, tyrosinase, melanogenesis








Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Role of human beta defensin 3 during type I interferon mediated antiviral response against vesicular stomatitis virus
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum